PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS.
$1,234,519
| Recipient | UNIVERSITY OF SYDNEY UEI CRPQN9NU7X28 |
|---|---|
| Award ID | 75F40122C00202 |
| Award amount | $1,234,519 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Food and Drug Administration |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN11 |
| Start date | Sep 27, 2022 |
| End date | Sep 29, 2026 |
| Place of performance | SILVER SPRING, MD |
| Record updated | Jul 31, 2025 |
View the official award record
More awards won by UNIVERSITY OF SYDNEY
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS
Department of Health and Human Services · $14,143,902 · Sep 30, 2022
DEVELOPMENT OF A LASER-BASED TESTING PLATFORM FOR GENERIC DRY POWDER.
Department of Health and Human Services · $687,062 · Sep 21, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids